Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrative Urology is a specialized medical practice and clinical research center based in Phoenix, Arizona, founded by Dr. Y. Mark Hong. The company is a global leader in the clinical implementation of the TULSA-PRO procedure, an MRI-guided, incision-free ultrasound ablation technology for the treatment of prostate cancer and benign prostatic hyperplasia (BPH). Integrative Urology is distinguished by its "whole-person" approach, which combines advanced minimally invasive surgical techniques with evidence-based holistic therapies, including nutrition, lifestyle medicine, and targeted supplementation. The center serves as a key clinical site for the development and validation of next-generation urological technologies, such as AI-powered treatment planning modules, and is recognized for achieving significant clinical milestones in the field of prostate care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrative Urology.